ACST - アカスティ・ファ―マ (Acasti Pharma Inc.) アカスティ・ファ―マ

 ACSTのチャート


 ACSTの企業情報

symbol ACST
会社名 Acasti Pharma Inc (アカスティ・ファ―マ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種    医療関連(Health Care)
概要 事業概要 --   アカスティ・ファ―マは、カナダのバイオ医薬品会社。脂質異常症と呼ばれる血中脂質異常や心血管障害の予防と治療法の研究、開発、商業化に従事する。主要製品は高トリグリセリド血症治療薬CaPreやOnemiaなど。それらの製品は、オキアミ油に由来するものである。主にカナダと米国で販売を行う。   Acasti is a biopharmaceutical innovator that has historically focused on the research, development and commercialization of prescription drugs using OM3 fatty acids delivered both as free fatty acids and bound-to-phospholipid esters, derived from krill oil. OM3 fatty acids have extensive clinical evidence of safety and efficacy in lowering triglycerides in patients with hypertriglyceridemia, or HTG. CaPre, an OM3 phospholipid therapeutic, was being developed for patients with severe HTG.
本社所在地 545 Promenade du Centropolis Suite 100 Laval Quebec H7T 0A3 CAN
代表者氏名
代表者役職名
電話番号
設立年月日 37288
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数
url www.acastipharma.com
nasdaq_url https://www.nasdaq.com/symbol/acst
adr_tso
EBITDA EBITDA ー
終値(lastsale) 1.24
時価総額(marketcap) 45483038.8
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 ACSTのテクニカル分析


 ACSTのニュース

   Acasti Pharma''s IV Hemorrhage Drug Candidate At Par With Oral Nimodipine  2022/05/18 15:20:26 Benzinga
Acasti Pharma Inc''s (NASDAQ: ACST ) pharmacokinetic (PK) bridging study with IV GTX-104, its lead drug candidate for Subarachnoid Hemorrhage (SAH), met all its planned study endpoints . The study''s primary objective was to evaluate the relative bioavailability of IV GTX-104 compared to oral nimodipine in healthy subjects, while the secondary objective was to assess its safety … Full story available on Benzinga.com
   Acasti says pharmacokinetic trial for lead asset met all study goals  2022/05/18 12:55:45 Seeking Alpha
Announcing topline data from a pharmacokinetic ((PK)) bridging study, the Canadian biopharma company Acasti Pharma (ACST) announced on Wednesday that its lead drug candidate, IV…
   Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All Endpoints  2022/05/18 11:30:00 GlobeNewswire
Bioavailability of IV GTX-104 compared favorably with the oral formulation of nimodipine, and no serious adverse events observed for GTX-104
   Update: Acasti Pharma CEO to Present at Microcap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 18th  2022/05/16 17:30:00 Wallstreet:Online
LAVAL, QC / ACCESSWIRE / May 16, 2022 / Acasti Pharma Inc. ("Acasti" or the "Company") (Nasdaq:ACST) and (TSX-V:ACST), today announced that Jan D''Alvise, Chief Executive Officer, has been invited to present at the Spring Into Action- Best Ideas …
   Acasti Pharma CEO to Present at Microcap Rodeo''s Spring into Action Best Ideas Virtual Conference on May 16th  2022/05/12 12:00:00 Wallstreet:Online
LAVAL, QC / ACCESSWIRE / May 12, 2022 / Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST)(TSXV:ACST), today announced that Jan D''Alvise, Chief Executive Officer, has been invited to present at the Spring Into Action- Best Ideas Investor …
   Acasti Pharma to Present at the B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference on April 28th  2022/04/25 12:33:15 Financial Post
LAVAL, Québec, April 25, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Prashant Kohli, Vice President of Commercial Operations of Acasti Pharma will be presenting at the B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference on Thursday, April 28, 2022 at 4:30 pm […]
   Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th  2022/03/09 13:30:00 GlobeNewswire
LAVAL, Quebec, March 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D’Alvise, President and Chief Executive Officer of Acasti Pharma will be presenting at the 32 nd Annual Oppenheimer Healthcare conference being held virtually March 15-17, 2022.
   Acasti Pharma Inc. (ACST) CEO Jan D''Alvise on Q3 2021 Results - Earnings Call Transcript  2022/02/14 21:39:05 Seeking Alpha
   Acasti Pharma GAAP EPS of -$0.09 misses by $0.01  2022/02/14 12:00:59 Seeking Alpha
Acasti Pharma press release (ACST): Q4 GAAP EPS of -$0.09 misses by $0.01.Cash, cash equivalents and short-term investments totaled $46.3 million as of December 31, 2021, compared…
   Earnings Scheduled For February 14, 2022  2022/02/14 08:54:01 Benzinga
Companies Reporting Before The Bell • Weber (NYSE: WEBR ) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million. • Kelly Services (NASDAQ: KELYB ) is expected to report earnings for its fourth quarter. • Westwater Resources (AMEX: WWR ) is likely to report earnings for its fourth quarter. • Scorpio Tankers (NYSE: STNG ) is expected to report quarterly loss at $0.75 per share on revenue of $151.10 million. • Kelly Services (NASDAQ: KELYA ) is expected to report quarterly earnings at $0.28 per share on revenue of $1.30 billion. • Garrett Motion (NASDAQ: GTX ) is projected to report quarterly earnings at $0.19 per share on revenue of $863.00 million. • Applied Genetic (NASDAQ: AGTC ) is expected to report earnings for its second quarter. • Alexander''s (NYSE: ALX ) is projected to report earnings for its fourth quarter. • Acasti Pharma (NASDAQ: ACST ) is estimated to report earnings for its third quarter. • Roivant Sciences (NASDAQ: ROIV ) is estimated to report earnings for its third quarter. • Olink Holding (NASDAQ: OLK ) is expected to report earnings for its fourth quarter. • Treehouse Foods (NYSE: THS ) is likely to report quarterly earnings at $0.09 per share on revenue of $1.12 billion. • Hawaiian Electric Indus (NYSE: HE ) is expected to report quarterly earnings at $0.42 per share on revenue of $681.34 million.
   Acasti Pharma Schedules Second Quarter Fiscal 2022 Business Update Conference Call  2021/11/04 12:30:00 Intrado Digital Media
Call to be held on Wednesday, November 10th at 1:00 PM Eastern Time Call to be held on Wednesday, November 10th at 1:00 PM Eastern Time
   Outrageous stocks: AT&T Inc. (NYSE:T 0.31%), Acasti Pharma Inc. (NASDAQ:ACST -0.29%)  2021/10/16 00:23:28 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Outrageous stocks: AT&T Inc. (NYSE:T 0.31%), Acasti Pharma Inc. (NASDAQ:ACST -0.29%) appeared first on Stocks Equity .
   Tiling stocks: Marathon Digital Holdings, Inc. (NASDAQ:MARA 10.38%), Acasti Pharma Inc. (NASDAQ:ACST 0.05%)  2021/10/11 23:45:38 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Tiling stocks: Marathon Digital Holdings, Inc. (NASDAQ:MARA 10.38%), Acasti Pharma Inc. (NASDAQ:ACST 0.05%) appeared first on Stocks Equity .
   Delighting stocks: Kala Pharmaceuticals, Inc. (NASDAQ:KALA -3.32%), Acasti Pharma Inc. (NASDAQ:ACST -4.44%)  2021/10/11 02:25:38 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Delighting stocks: Kala Pharmaceuticals, Inc. (NASDAQ:KALA -3.32%), Acasti Pharma Inc. (NASDAQ:ACST -4.44%) appeared first on Stocks Equity .
   Hypnotizing stocks: CSX Corporation (NASDAQ:CSX 1.46%), Acasti Pharma Inc. (NASDAQ:ACST -0.25%)  2021/10/02 00:47:24 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Hypnotizing stocks: CSX Corporation (NASDAQ:CSX 1.46%), Acasti Pharma Inc. (NASDAQ:ACST -0.25%) appeared first on Stocks Equity .

 関連キーワード  (― 米国株 アカスティ・ファ―マ ACST Acasti Pharma Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)